The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 3, 2013, Pages 195-201

  Sorour, Amani ^a   Ayad, Mona Wagdy ^a   Kassem, Hala ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; XRCC3 PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CELL PROTECTION; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; EGYPT; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BASE SEQUENCE; DNA PRIMERS; DNA REPAIR; DNA-BINDING PROTEINS; GENOTYPE; HUMANS; LEUKEMIA, MYELOID, ACUTE; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84874343383     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0278     Document Type: Article

References (23)

1. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. (2000) Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 159:79-86.
2. Broughton BC, Steingrimsdottir H, Lehmann AR (1996) Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutat Res 15:209-211. (Pubitemid 26070995)
3. Dinkova-Kostova AT, Talalay P (2010) NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys 501:116-123.
4. El-Din M, Raslan H, Abdel-Hamid S, Makhlouf M (2010) Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Comp Clin Pathol 10:1007.
5. Fern L, Pallis M, Ian Carter G, et al. (2004) Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS. Br J Haematol 126:63-71. (Pubitemid 38859483)
6. Guha N, Chang JS, Chokkalingam AP, et al. (2008) NQO1 Polymorphisms and de novo childhood leukemia: a huge review and meta-analysis. Am J Epidemiol 168:1221-1232.
7. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366-374. (Pubitemid 32467046)
8. Krajinovic M, Sinnett H, Richer C, et al. (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97:230-236. (Pubitemid 34019960)
9. Kuptsova N, Kopecky KJ, Godwin J, et al. (2007) Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 109:3936-3944. (Pubitemid 46641746)
10. Kuptsova-Clarkson N, Ambrosone CB, Weiss J, et al. (2010) XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. Int J Mol Epidemiol Genet 1:278-294.
11. Loeb LA (1991) Mutation phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079.
12. Lo'pez Cima FM, Gonza'lez Arriaga P, Garci'a Castro L, et al. (2007) Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain. BMC Cancer 7:162.
13. Lunn RM, Helzlsouer KJ, Parshad R, et al. (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21:551-555. (Pubitemid 30214005)
14. Matullo G, Palli D, Peluso M, et al. (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22:1437-1445. (Pubitemid 32898701)
15. O?zcan A, Pehlivan A, Gaye A, et al. (2011) Polymorphisms of the DNA repair gene XPD (751) andXRCC1 (399) correlate with risk of hematological malignancies in Turkish population. Afr J Biotechnol 10:8860-8870.
16. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C (2002) Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99:1909-1912. (Pubitemid 34525468)
17. Rosvold EA, McGlnnn KA, Lustbader ED, Buetow KH (1995) Identification of an NAD(P)H:quinoneoxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 5:199-206.
18. Seedhouse C, Bainton R, Lewis M, et al. (2002) The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 100:3761-3766. (Pubitemid 35303949)
19. Shen M, Hung RJ, Brennan P, et al. (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a casecontrol study in Northern Italy. Cancer Epidemiol Biomarkers Prev 12:1234-1240. (Pubitemid 37499450)
20. Shen MR, Jones IM, Mohrenweiser H (1998) Non conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604-608. (Pubitemid 28099464)
21. Siegel D, McGuinness SM, Winski SL, Ross D (1999) Genotypephenotype relationships in studies of a polymorphism in NAD(P)H:quinoneoxidoreductase Pharmacogenetics 9:113- 121. (Pubitemid 29176730)
22. Skjelbred CF, Saebø M, Wallin H, et al. (2006) Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer 6:67.
23. Voso MT, Fabiani E, D'Alo' F, et al. (2007) Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol 18:1523-1528. (Pubitemid 47365486)